| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Bio-Rad Laboratories, Inc.
| NYSE
|
BIO
|
115.45
|
|
+0.06
(0.05%)
| 3.29B
|
|
|
Bio-Rad Laboratories, Inc. (Bio-Rad) manufactures and supplies the life science
research, healthcare, analytical chemistry and other markets with a range of ...
| |
| |
|
|
Qiagen NV
| NASDAQ
|
QGEN
|
18.73
|
|
+0.05
(0.27%)
| 4.38B
|
|
|
Provides genetically oriented technlogy. The Company provides enabling
technologies and products for separating and purifying nucleic acids (DNA and
RNA).
| |
| |
|
|
Qiagen NV
| FRA
|
QIA
|
14.44
|
|
-0.24
(-1.66%)
| 3.38B
|
|
|
Provides genetically oriented technlogy. The Company provides enabling
technologies and products for separating and purifying nucleic acids (DNA and
RNA).
| |
| |
|
|
Qiagen NV
| ETR
|
QIA
|
14.45
|
|
-0.22
(-1.47%)
| 3.38B
|
|
|
Provides genetically oriented technlogy. The Company provides enabling
technologies and products for separating and purifying nucleic acids (DNA and
RNA).
| |
| |
|
|
The Medicines Company
| NASDAQ
|
MDCO
|
33.37
|
|
+0.84
(2.57%)
| 1.87B
|
|
|
The Medicines Company is a pharmaceutical company focused on the treatment of
critical care patients through the delivery of medicines to the global ...
| |
| |
|
|
Bio-Rad Laboratories, Inc.
| NYSE
|
BIO.B
|
115.41
|
|
0.00
(0.00%)
| 3.29B
|
|
|
Bio-Rad Laboratories, Inc. (Bio-Rad) manufactures and supplies the life science
research, healthcare, analytical chemistry and other markets with a range of ...
| |
| |
|
|
BIO-RAD LABS INC.DL-,0001
| FRA
|
BUWA
|
88.54
|
|
-0.50
(-0.56%)
|
|
|
|
|
|
|
MEDICINES CO. DL-,001
| FRA
|
MZN
|
25.20
|
|
-1.36
(-5.13%)
|
|
|
|
|
|
